We are pleased to announce the appointment of Jonathan Kimmelman, PhD, to the role of Director, Biomedical Ethics Unit, Faculty of Medicine, McGill University. Dr. Kimmelman has been ably serving in this role as Interim Director since 2015.

As Director, Dr. Kimmelman will lead the Biomedical Ethics Unit in carrying out its mission to support scholarly research, clinical services, teaching and public outreach. He will be responsible for the overall administration of the unit, will work to ensure continued excellence and growth in program development and will establish new directions related to biomedical ethics on both the educational and research fronts.

Following undergraduate studies at Duke University in Durham, North Carolina, Dr. Kimmelman earned his PhD in Molecular Biophysics and Biochemistry at Yale University. He first came to McGill in 2002 for his postdoctoral training with the Biomedical Ethics Unit. An Associate Professor in Social Studies of Medicine and a member in the Biomedical Ethics Unit, he also holds cross appointments in the Departments of Medicine, Epidemiology, Biostatistics and Occupational Health and Human Genetics. His research focuses on ethical, policy and scientific dimensions of drug and diagnostics development.

Dr. Kimmelman founded and directs the Studies of Translation, Ethics and Medicine (STREAM) and has authored a book on gene therapy and ethics, as well as numerous publications in high impact journals such as JAMA and Nature, among others. He serves on the editorial boards of a number of journals including PLoS Biology and is Deputy Editor at Clinical Trials. Dr. Kimmelman has extensive experience both in Canada and the United States serving on advisory bodies and committees including chairing the Ethics Committee of the International Society of Stem Cell Research and serving on a number of committees for the National Academy of Sciences.

Dr. Kimmelman is a member of a number of societies including the International Society of Stem Cell Research, the Society for Clinical Trials and the American Society for Bioethics and Humanities. From 2008 to 2013 he held a CIHR New Investigator Award for his work on ethics in translational research. In 2014 he was the recipient of the Friedrich Wilhelm Bessel Research Award from the Humboldt Foundation in Germany.

Please join us in congratulating Dr. Kimmelman on this appointment and in wishing him continued success in leading the Biomedical Ethics Unit.

Dr. David Eidelman

Vice-Principal (Health Affairs)

Dean of the Faculty of Medicine

Dr. Mara Ludwig

Vice-Dean, Academic Affairs



March 22, 2018